摘要
叶下珠是分布于我国南方地区广泛应用于临床的一种传统中草药,近年来国内外对叶下珠及其复方制剂抗肝纤维化作用实验研究有较多报道。肝纤维化是肝硬化的前期阶段,肝硬化是不可逆转的严重的肝脏病变,但现代研究说明肝纤维化也是可以逆转的。本文就叶下珠及其复方制剂抗肝纤维化的作用机制文献进行整理和分类,为相关研究提供借鉴。
Phyllanthus urinaria is a kind of traditional Chinese medicine in China,widely distributed in southern China. In recent years at home and abroad,Phyllanthus urinaria and its compound preparation of anti liver fibrosis experimental research were reported. Liver fibrosis is the early stage of cirrhosis,which is a serious and irreversible disease of the liver,but modern studies have shown that liver fibrosis is reversible. The mechanism of the Phyllanthus urinaria and its compound anti hepatic fibrosis by sorting and classification can provide the reference for the related research.
引文
[1]夏超,王佳佳,李芳群,等.美洲大蠊水提取物对免疫性肝纤维化大鼠的保护作用[J].安徽医科大学学报,2016,51(2):199-204.
[2]Hansen T,Christensen E. Cirrhosis and liver fibrosis are potentially reversible[J]. Ugeskrift for Laeger,2015,177(48):V06 150 527.
[3]赵嗣霞,张如松,杨苏蓓.积雪草苷抗大鼠免疫性肝纤维化作用研究[J].中国现代应用药学,2017,34(5):666-670.
[4]Sekaran SD,Tang YQ,Lee SH. Phyllanthus spalocal plant with multiple medicinal properties[J]. Journal of Health and Tran-slational Medicine,2014,17(2):1-8.
[5]戴卫波,肖文娟.叶下珠药理作用研究进展[J].药物评价研究,2016,39(3):498-500.
[6]杨孟妮,张慧,刘娟,等.叶下珠化学成分研究[J].中草药,2016,47(20):3 573-3 577.
[7]程艳刚,裴妙荣,孔祥鹏,等.叶下珠化学成分和药理作用研究进展[J].辽宁中医药大学学报,2016,18(4):238-242.
[8]Girish C,Pradhan SC. Hepatoprotective activities of picroliv,curcumin,and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice[J]. Journal of Pharmacology&Pharmacotherapeutics,2012,3(2):149-155.
[9]尹连红,于浩,彭金咏.四氯化碳诱导肝损伤的分子机制及中药干预的研究进展[J].中国现代应用药学,2015,32(9):1 147-1 155.
[10]范适,左家哺,饶力群.叶下珠提取物对CCl4致小鼠化学性肝损伤保护作用[J].江苏建筑职业技术学院学报,2016,16(3):27-31.
[11]Elliott SJ,Koliwad SK. Redox control of ion channel activity in vascular endothelial cells by glutathione[J]. Microcirculation,1997,4(3):341-347.
[12]Valko M,Leibfritz D,Moncol J,et al. Free radicals and antioxidants in normal physiological functions and human disease[J]. The International Journal of Biochemistry&Cell Biology,2007,39(1):44-84.
[13]陈斯泰,何素,李常青.叶下珠复方Ⅱ号对四氯化碳致小鼠急性肝损伤的保护作用[J].中国热带医学,2016,16(8):766-769.
[14]Kitaura Y,Chikazawa N,Tasaka T,et al. Transforming growth factorβ1contributes to the invasiveness of pancreatic ductal adenocarcinoma cells throughthe regulation of CD24 expression. Pancreas.2011,40(7):1 034-1 042.
[15]Valcourt U,Carthy J,Okita Y,et al. Analysis of epithelial-mesenchy-mal transition induced by transforming growth factorβ[J].Methods Mol Biol,2016(1 344):147-181.
[16]Gauldie J,Bonniaud P,Sime P,et al. TGF-beta,Smad3 and the process of progressive fibrosis,Biochem Soc Trans[J]. 2007,35(4):661-664.
[17]Gouville ACD,Boullay V,Krysa G,et al. Inhibition of TGF-β,signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis[J]. Br J Pharmacol,2005,145(2):166–177.
[18]Krithika R,Jyothilakshmi V,Prashantha K,et al. Mechanism of protective effect of phyllanthin against carbon tetrachloride-induced hepatotoxicity and experimental liver fibrosis in mice[J].Toxicology Mechanisms&Methods,2015,25(9):1-10.
[19]Olaso E,Friedman SL. Molecular regulation of hepatic fibrogenesis[J]. Journal of Hepatology,1998,29(5):836.
[20]Tsai WC,Hsu SD,Hsu CS,et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis[J]. J Clin Invest,2012,122(8):2 884-2 897.
[21]Vincent R,Sanyal A. Recent Advances in Understanding of NASH:MicroRNAs as Both Biochemical Markers and Players[J].Current Pathobiology Reports,2014,2(3):109-116.
[22]罗来育,李常青,李小翬,等.叶下珠复方Ⅱ号对肝星状细胞增殖和miR-122/KLF6表达的影响[J].热带医学杂志,2015,15(1):8-12.
[23]时博,史晶晶,秦华珍.郁金含药血清对HSC-T6细胞增殖抑制作用的影响[J].中医学报,2017,32(5):789-792.
[24]赵敏,李常青,赵舫,等.叶下珠复方Ⅱ号对肝星状细胞TGF-β1及I型胶原的影响[J].中国热带医学,2012,12(5):538-541.
[25]杨新疆,齐翠花,郑勇,等. SB203580对肝纤维化大鼠肝脏Ⅰ、Ⅲ型胶原蛋白表达的影响[J].世界华人消化杂志,2014,22(3):310-318.
[26]古晓娜,刘占旗,战景明,等. MAPKs在Bcl-2家族调控细胞凋亡中的作用[J].环境卫生学杂志,2008,35(2):65-69.
[27]Yu FX,Teng YY,Zhu QD,et al. lnhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis[J]. Biochem Cell Biol,2014,92(5):406-412.
[28]Guo CJ,Pan Q,Li DG,et al. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell:An essential role for apoptosis[J]. Journal of Hepatology,2009,50(4):766-778.
[29]夏曦,赵敏,李常青,等.叶下珠复方Ⅱ号对肝星状细胞凋亡和miR-16/Bcl-2表达的影响[J].广州中医药大学学报,2013,30(5):86-92.
[30]Duval F,Morenocuevas JE,Maldonadobernal C,et al. Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response[J]. International Journal of Inflammation,2015(4):943-957.
[31]孙华丽,张建军.组织金属蛋白酶及其抑制因子与肝纤维化[J].西南军医,2010,12(1):81-83.
[32]钱鹏,陈剑群.青蒿琥酯抗肝纤维化作用机制的研究进展[J].重庆医学,2017,46(2):269-271.
[33]盛扬,李常青,刘妮,等.叶下珠复方Ⅱ号对HSC-T6增殖及TIMP-1mRNA表达的影响[J].中国热带医学,2008,8(2):204-205.
[34]李彩东,梁云,吴斌,等.复方苦味叶下珠胶囊对实验性肝损伤的保护作用[J].中药药理与临床,2005,21(2):53-54.
[35]鲁玉辉,符林春.叶下珠复方在体外细胞培养中抗HBV活性的研究[J].中国热带医学,2007,7(2):196-197.
[36]蒋菁蓉,张天洪,钟森.叶下珠治疗慢性乙型肝炎研究概况[J].实用中医内科杂志,2013(4):151-154.
[37]孟月珍,陈宝明.略论刘渡舟教授治疗肝病特色[J].山西中医学院学报,2002,3(3):29-30.
[38]叶永安.慢性乙型肝炎的中西医结合治疗[J].中国中西医结合杂志,2008,28(1):8-9.
[39]黄桥华,郭晓静,刘小云.叶下珠抑制人肾癌786-0细胞增殖作用的研究[J].中国中医药现代远程教育,2017,15(11):145-146.
[40]黄远媛.叶下珠汤治疗乙肝肝纤维化50例临床观察[J].中国中医药信息杂志,2003,10(9):55-56.
